Which pain block works best for sleeve gastrectomy?
NCT ID NCT07654556
First seen Jun 20, 2026 · Last updated Jun 20, 2026
Summary
This study will compare two types of nerve blocks (M-TAPA and ESP block) to see which provides better pain relief after laparoscopic sleeve gastrectomy. Sixty-four patients will receive an injection of the numbing medicine bupivacaine in one of the two block techniques. Pain scores will be measured for 48 hours after surgery to determine which approach is more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupivacaine
What this could lead to
If one block proves better, it could improve pain control and reduce opioid use after weight-loss surgery.
What could go wrong
This is a small, early-stage study with only 64 participants, so results may not apply to all patients. Both blocks are already used, so no major breakthrough is expected.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.